At a Glance
HealthTech Capital is a Nashville-based venture capital firm founded in 2014 with exclusive focus on healthcare technology investments. With approximately $200 million in assets under management, the firm has established itself as a significant player in the healthcare venture ecosystem, leveraging deep expertise in digital health, medical devices, and healthcare services technology.
The firm's investment thesis centers on partnering with entrepreneurs building transformative healthcare technologies that improve patient outcomes while reducing costs—a dual mandate that reflects the healthcare industry's ongoing pressure to deliver better care more efficiently. HealthTech Capital typically invests in Series A and later-stage rounds, positioning themselves to support companies that have proven initial product-market fit and are ready to scale their healthcare solutions.
HealthTech Capital's portfolio includes several notable healthcare technology companies such as Teladoc, Livongo, and Oscar Health—companies that have played pivotal roles in transforming how healthcare is delivered and accessed. These investments demonstrate the firm's ability to identify and support companies at the forefront of healthcare innovation. The firm's Nashville headquarters provides a strategic advantage, as Tennessee has emerged as a significant healthcare hub with lower operating costs than traditional coastal markets, while still offering access to major healthcare systems and medical research institutions.
“Partnering with entrepreneurs building transformative healthcare technologies that improve patient outcomes and reduce costs.”
HealthTech Capital primarily invests at the Series A, Series B+ stages. This means they focus on companies that are scaling their go-to-market after proving product-market fit.
HealthTech Capital is headquartered in Nashville, TN. Many of their portfolio companies are also based in this region, though they invest across geographies.
HealthTech Capital focuses on investments in Digital Health, Biotech. Their portfolio reflects deep expertise and networks within these sectors.
HealthTech Capital's typical investment check size ranges from $2M to $15M. Actual amounts may vary based on the stage, sector, and specific opportunity.
HealthTech Capital manages approximately $200M in assets under management (AUM) across their funds.
